1 completed, 1 terminated. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
Follow lanreotide: new trials by email Literature Review of lanreotide trials Research Report on lanreotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acromegaly Combination Treatment Study Pegvisomant, Octreotide LAR, Lanreotide - Acromegaly | Not applicable | Terminated | Cedars-Sinai Medical Center | 76 | 2012-03-29 | 2023-01-04 |
| Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients Pegvisomant, Somatostatin analog (lanreotide or octreotide) - Acromegaly, Insulin Resistance | Not applicable | Completed | University of Aarhus | 18 | 2008-06-01 | 2012-01-26 |
Acromegaly (2) · Glucose Intolerance (1) · Insulin Resistance (1) · Pituitary Diseases (1)
Cedars-Sinai Medical Center (1) · University of Aarhus (1)
Denmark (1) · United States (1)